Home › Funds › KVP Capital Advisors, LP › ERAS

KVP Capital Advisors, LP position in ERAS

ERASCA INC · Health Care

KVP Capital Advisors, LP reported holding 455,000 shares of ERAS (ERASCA INC) in its Q2 2026 13F filing — a position valued at US$8.3M, representing 6.12% of its reported portfolio and ranking #3 among its reported holdings. KVP Capital Advisors, LP has disclosed ERAS holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)455.00K sh
Reported value held$8.34M
Portfolio Weight6.12%
First reportedQ1 2026
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How KVP Capital Advisors, LP's ERAS position evolved

KVP Capital Advisors, LP first disclosed a stake in ERAS in Q1 2026 at 340,000 shares (US$5.5M). The position peaked in Q2 2026 at 455,000 shares, worth US$8.3M. Across 2 filings, KVP Capital Advisors, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 455,000 shares valued at US$8.3M — an increase of 115,000 shares quarter over quarter.. Notable position changes include a 34% increase in Q2 2026 (shares fell 20% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 340.00K $5.50M New
Q2 2026 455.00K $8.34M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ERAS and 13F data

ERAS (ERASCA INC) is a Health Care company. 78 other funds we track also report a position in ERAS — the largest reported positions include Frazier Life Sciences Management, L.P. (US$457.5M), RTW INVESTMENTS, LP (US$328.8M), Venrock Adviser, LLC (US$327.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ERAS

All ERAS fund holders →

FAQ

How long has KVP Capital Advisors, LP held ERAS?

KVP Capital Advisors, LP has disclosed ERAS holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is KVP Capital Advisors, LP's current position in ERAS?

As of Q2 2026, KVP Capital Advisors, LP holds 455.00K shares of ERAS (ERASCA INC), valued at $8.34M, representing 6.12% of its reported portfolio and ranking #3.

Has KVP Capital Advisors, LP been buying or selling ERAS?

In the latest 13F filing (Q2 2026), KVP Capital Advisors, LP increased its position in ERAS. The position peaked in Q2 2026 at 455.00K shares.

Which other funds hold ERAS?

Other major institutional holders of ERAS include Frazier Life Sciences Management, L.P., RTW INVESTMENTS, LP, Venrock Adviser, LLC, among 78 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.